New York’s stricter payment enforcement is reshaping dispensary purchasing, a federal contract dispute involving Curaleaf could carry broad legal consequences, and Ohio cannabis sales have surpassed $1 billion for the year.
Tag: Curaleaf
Cannabis M&A Escalates as Skydance Sets Its Power Structure
Curaleaf raised its hostile offer for Aurora Cannabis, while a cannabinoid drug developer reported progress toward an FDA veterinary pathway. In entertainment, Paramount named the leadership structure expected to oversee its combined business with Warner Bros. Discovery.
Cannabis Deal Fight Escalates as Streaming Prices Climb
Aurora Cannabis has taken its battle with Curaleaf to securities regulators, while a federal watchdog identified procedural gaps in U.S. drug scheduling. Disney, meanwhile, is using another round of Disney+ and Hulu price increases to push subscribers toward bundles.
Cannabis Contract Shock and Hollywood’s Merger Standoff
A federal appeals court erased a $31.8 million cannabis verdict, Ohio activated detailed product rules, and Paramount’s contested Warner Bros. acquisition moved toward court-ordered settlement talks.
Federal Hemp Ban Delayed
President Trump signed a temporary reprieve for much of the hemp-derived THC market, California highlighted nearly $8.4 billion in cannabis tax revenue, and Aurora formally rejected Curaleaf’s hostile takeover bid.
Federal Hemp Market Gets a One-Month Reprieve
Federal hemp restrictions are delayed until December, Aurora rejects Curaleaf’s hostile takeover bid, and California reports $8.4 billion in cannabis tax revenue alongside a major illicit-market seizure.
Federal Hemp THC Ban Delay
Congress has sent a temporary hemp THC reprieve to the White House, while Curaleaf and Aurora escalate a major cannabis takeover battle. In Los Angeles, the Lucas Museum of Narrative Art has detailed its long-awaited public opening.
